Pago Pago, AS (April 30, 2020) – The American Samoa Department of Health organized a nationwide mass drug administration (MDA) campaign to accelerate the elimination of lymphatic filariasis (LF) from 22 September to 9 November 2019. Using the triple-drug therapy strategy, American Samoa was the first endemic setting within the Global Programme to Eliminate Lymphatic Filariasis to complete two rounds of triple-drug MDA at the program scale. Support was provided by the United States Centers for Disease Control and Prevention (US CDC) and the Pacific Island Health Officers Association (PIHOA). Prior to the MDA in 2019, there were media campaigns, along with social mobilization and training of health staff, aimed at securing high treatment coverage. Approximately 30 000 people were treated in the second round of triple-drug MDA, and the reported drug coverage was 53.6%. Although reported coverage was less than the recommended minimum of 65%, provisional surveyed coverage was 75.2%, indicating that an adequate rate was achieved. Click HERE for the full World Health Organization – Western Pacific Region Office (WPRO) Neglected Tropical Diseases(NTD) Newsletter.